Clinical Trials · NCT04989348
Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Shanghai First Maternity and Infant Hospital
- Enrollment
- 240
- Start date
- Aug 2021
- Locations
- 1 site, China
- Primary endpoint
- euploid blastocyst formation rate